High HSP90 and CHIP expression, with reduced ARF expression, has also been identified in NSCLC [78]; high HSP90 or combined HSP90/CHIP expression, with low ARF expression, indicates worse overall survival rates. Here, CDKN2A is linked to non-small cell lung carcinoma.